RaySearch Laboratories: Interim report April - June 2024
SECOND QUARTER (APRIL-
- Order intake
SEK 290.3 M (239.2) - Net sales SEK 318.9 M (239.5)
- Operating profit SEK 79.3 M (18.2)
- Profit after tax SEK 61.4 M (10.9)
- Earnings per share before/after dilution SEK 1.79 (0.32)
- Cash flow from operating activities SEK 154.6 M (67.2)
- Order backlog SEK 1,790.5 M (1,954.9) at the end of the period
HALF-YEAR (JANUARY-
- Order intake
SEK 528.8 M (445.8) - Net sales SEK 576.1 M (469.6)
- Operating profit
SEK 125.1 M (41.9) - Profit after tax SEK 98.1 M (28.5)
- Earnings per share before/after dilution SEK 2.86 (0.83)
- Cash flow from operating activities SEK 321.9 M (220.9)
SIGNIFICANT EVENTS DURING THE SECOND QUARTER
- Raigmore Hospital in
Scotland selects RayCare. - RaySearch and C-RAD sign collaboration agreement.
- RayCare has been certified to be interoperable with Varian TrueBeam.
- RayStation Used for First-Ever Radiotherapy Treatment with Hitachi's OXRAY system.
- The New York Proton Center expands their RayStation installation.
SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD
There have been no significant events after the end of the reporting period.
WEBCAST
CEO
Link to webcast: RaySearch Q2, 2024
The information contained in this interim report is such that RaySearch Laboratories AB (publ) is obliged to disclose under the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication on
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
Telephone: +46 (0) 8 510 530 00
[email protected]
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/raysearch-laboratories/r/interim-report-april---june-2024,c4025135
The following files are available for download:
RaySearch Interim report Q2 2024 |
View original content:https://www.prnewswire.com/news-releases/raysearch-laboratories-interim-report-april---june-2024-302224207.html
SOURCE RaySearch Laboratories
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Morgan Stanley more than doubles Lenovo price target on AI-driven growth
- /C O R R E C T I O N -- Artizent Inc./
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share